A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease

Hepatitis C virus (HCV) infection is a risk factor for chronic kidney disease (CKD). However, it remains unclear whether interferon-based therapy (IBT) for HCV was associated with reduced risk of CKD. From the Taiwan National Health Insurance Research Database, we identified 919 patients who receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-Chun, Hwang, Shang-Jyh, Li, Chung-Yi, Wu, Chia-Pin, Lin, Li-Chu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616715/
https://www.ncbi.nlm.nih.gov/pubmed/26266379
http://dx.doi.org/10.1097/MD.0000000000001334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616715/
https://www.ncbi.nlm.nih.gov/pubmed/26266379
http://dx.doi.org/10.1097/MD.0000000000001334

Ejemplares similares